<html>
<head>
    <meta charset="UTF-8">
    <title>paper-trackr newsletter</title>
</head>
<body style="font-family: Georgia, serif; background-color: #f4f4f4; padding: 20px; font-size: 16px;">
    <div style="background-color: white; padding: 30px; max-width: 700px; margin: auto; box-shadow: 0 2px 8px rgba(0,0,0,0.1);">
        <div style="display: flex; justify-content: space-between; align-items: center; border-bottom: 2px solid #000000; margin-bottom: 10px;">
  <h1 style="font-size: 28px; margin: 0;">paper-trackr newsletter</h1>
  <a href="https://felipevzps.github.io/" style="font-size: 16px; text-decoration: none; color: #1a0dab;">← back to my website</a>
</div>
        <p style="color: gray; font-size: 16px;"><strong>Monday, 28 April 2025</strong></p>
        <p style="font-size: 16px;">Hello science reader,</p>
        <p style="font-size: 16px;">Welcome to your daily dose of research. Dive into the latest discoveries from the world of science!<div style="border-left: 4px solid #ccc; padding-left: 12px; margin-top: 20px; color: gray; font-size: 15px; font-style: italic;">
    This newsletter was built with 
    <a href="https://github.com/felipevzps/paper-trackr" style="color: #1a0dab; text-decoration: none;">paper-trackr</a> and is tailored to my interests.<br>
    Customize your own filters and receive personalized updates.
</div></p>
        <hr style="margin: 20px 0;">
        
            <div style="margin-bottom: 30px;">
                <h2 style="color: #000000; font-size: 22px;">Present progress in biomarker discovery of endometrial cancer by multi-omics approaches. </h2>
                <p style="font-size: 14px; text-align: justify; margin-top: -10px; margin-bottom: 10px;"> An Y, Feng Q, Jia L, Sha X, Zhang T, Lu L, Wang R, Bai B.</p>
         
                <table role="presentation" width="100%" cellspacing="0" cellpadding="0" style="font-size:16px; margin-bottom: 12px;">
                    <tr>
                        <td align="left" style="font-style: italic;">
                            Source: MED
                        </td>
                        <td align="right" style="font-style: italic;">
                            Published: 2025-04-26
                        </td>
                    </tr>
                </table>
            
                <p><span style="background-color: #84d69a; color: #000000; padding: 4px 8px; border-radius: 12px; font-size: 14px; box-shadow: 1px 1px 3px rgba(0, 0, 0, 1);">machine learning, bioinformatics, genomics</span></p>
                <p style="font-size: 16px; text-align: justify; margin-bottom: 10px;"><span style="font-weight: bold; font-size: 16px;">tl;dr:</span> A review of the recent progress and future prospects in the application of multi-omics technologies in EC research, emphasizing the potential of the technology in uncovering novel biomarkers.</p><p style="font-size: 16px; text-align: justify;"><span style="font-weight: bold; font-size: 16px;">Abstract:</span> Endometrial cancer (EC), a prevalent and intricate disease, is associated with a poor prognosis among gynecological malignancies. Its incidence rising globally underscores the urgent need for biomarkers detection in both research and clinical settings. Over the past decade, we've witnessed rapid advancements in biological methodologies and techniques. A multitude of omics technologies, encompassing genomic/transcriptomic sequencing and proteomic/metabolomic mass spectrometry, have been extensively employed to analyze both tissue and liquid samples derived from EC patients. The integration of multi-omics data has not only broadened our understanding of the disease but also unearthed valuable biomarkers specific to EC. This review encapsulates the recent progress and future prospects in the application of multi-omics technologies in EC research, emphasizing the potential of multi-omics in uncovering novel biomarkers and enhancing clinical assessments.</p>
                <p><a href="https://pubmed.ncbi.nlm.nih.gov/40281423/" style="color: #1a0dab; font-size: 16px;">Read full paper</a></p>
            </div>
            <hr style="border: none; border-top: 1px solid #ccc;">
        

            <div style="margin-bottom: 30px;">
                <h2 style="color: #000000; font-size: 22px;">Diabetic neuropathy: cutting-edge research and future directions.</h2>
                <p style="font-size: 14px; text-align: justify; margin-top: -10px; margin-bottom: 10px;"> Yang Y, Zhao B, Wang Y, Lan H, Liu X, Hu Y, Cao P.</p>
         
                <table role="presentation" width="100%" cellspacing="0" cellpadding="0" style="font-size:16px; margin-bottom: 12px;">
                    <tr>
                        <td align="left" style="font-style: italic;">
                            Source: MED
                        </td>
                        <td align="right" style="font-style: italic;">
                            Published: 2025-04-25
                        </td>
                    </tr>
                </table>
            
                <p><span style="background-color: #84d69a; color: #000000; padding: 4px 8px; border-radius: 12px; font-size: 14px; box-shadow: 1px 1px 3px rgba(0, 0, 0, 1);">machine learning, bioinformatics, genomics</span></p>
                <p style="font-size: 16px; text-align: justify; margin-bottom: 10px;"><span style="font-weight: bold; font-size: 16px;">tl;dr:</span> A comprehensive overview of current understanding and future directions in diabetic neuropathy research and management.</p><p style="font-size: 16px; text-align: justify;"><span style="font-weight: bold; font-size: 16px;">Abstract:</span> Diabetic neuropathy (DN) is a prevalent and debilitating complication of diabetes mellitus, significantly impacting patient quality of life and contributing to morbidity and mortality. Affecting approximately 50% of patients with diabetes, DN is predominantly characterized by distal symmetric polyneuropathy, leading to sensory loss, pain, and motor dysfunction, often resulting in diabetic foot ulcers and lower-limb amputations. The pathogenesis of DN is multifaceted, involving hyperglycemia, dyslipidemia, oxidative stress, mitochondrial dysfunction, and inflammation, which collectively damage peripheral nerves. Despite extensive research, disease-modifying treatments remain elusive, with current management primarily focusing on symptom control. This review explores the complex mechanisms underlying DN and highlights recent advances in diagnostic and therapeutic strategies. Emerging insights into the molecular and cellular pathways have unveiled potential targets for intervention, including neuroprotective agents, gene and stem cell therapies, and innovative pharmacological approaches. Additionally, novel diagnostic tools, such as corneal confocal microscopy and biomarker-based tests, have improved early detection and intervention. Lifestyle modifications and multidisciplinary care strategies can enhance patient outcomes. While significant progress has been made, further research is required to develop therapies that can effectively halt or reverse disease progression, ultimately improving the lives of individuals with DN. This review provides a comprehensive overview of current understanding and future directions in DN research and management.</p>
                <p><a href="https://pubmed.ncbi.nlm.nih.gov/40274830/" style="color: #1a0dab; font-size: 16px;">Read full paper</a></p>
            </div>
            <hr style="border: none; border-top: 1px solid #ccc;">
        

            <div style="margin-bottom: 30px;">
                <h2 style="color: #000000; font-size: 22px;">Cross-disciplinary perspectives on the potential for artificial intelligence across chemistry.</h2>
                <p style="font-size: 14px; text-align: justify; margin-top: -10px; margin-bottom: 10px;"> Mroz AM, Basford AR, Hastedt F, Jayasekera IS, Mosquera-Lois I, Sedgwick R, Ballester PJ, Bocarsly JD, Antonio Del Río Chanona E, Evans ML, Frost JM, Ganose AM, Greenaway RL, Kuok Mimi Hii K, Li Y, Misener R, Walsh A, Zhang D, Jelfs KE.</p>
         
                <table role="presentation" width="100%" cellspacing="0" cellpadding="0" style="font-size:16px; margin-bottom: 12px;">
                    <tr>
                        <td align="left" style="font-style: italic;">
                            Source: MED
                        </td>
                        <td align="right" style="font-style: italic;">
                            Published: 2025-04-25
                        </td>
                    </tr>
                </table>
            
                <p><span style="background-color: #f4dbac; color: #000000; padding: 4px 8px; border-radius: 12px; font-size: 14px; box-shadow: 1px 1px 3px rgba(0, 0, 0, 1);">bioinformatics, workflow, automated</span></p>
                <p style="font-size: 16px; text-align: justify; margin-bottom: 10px;"><span style="font-weight: bold; font-size: 16px;">tl;dr:</span> From accelerating simulations and exploring chemical space, to experimental planning and integrating automation within experimental labs, artificial intelligence (AI) is changing the landscape of chemistry.</p><p style="font-size: 16px; text-align: justify;"><span style="font-weight: bold; font-size: 16px;">Abstract:</span> From accelerating simulations and exploring chemical space, to experimental planning and integrating automation within experimental labs, artificial intelligence (AI) is changing the landscape of chemistry. We are seeing a significant increase in the number of publications leveraging these powerful data-driven insights and models to accelerate all aspects of chemical research. For example, how we represent molecules and materials to computer algorithms for predictive and generative models, as well as the physical mechanisms by which we perform experiments in the lab for automation. Here, we present ten diverse perspectives on the impact of AI coming from those with a range of backgrounds from experimental chemistry, computational chemistry, computer science, engineering and across different areas of chemistry, including drug discovery, catalysis, chemical automation, chemical physics, materials chemistry. The ten perspectives presented here cover a range of themes, including AI for computation, facilitating discovery, supporting experiments, and enabling technologies for transformation. We highlight and discuss imminent challenges and ways in which we are redefining problems to accelerate the impact of chemical research via AI.</p>
                <p><a href="https://pubmed.ncbi.nlm.nih.gov/40278836/" style="color: #1a0dab; font-size: 16px;">Read full paper</a></p>
            </div>
            <hr style="border: none; border-top: 1px solid #ccc;">
        

            <div style="margin-bottom: 30px;">
                <h2 style="color: #000000; font-size: 22px;">The dynamic immune behavior of primary and metastatic ovarian carcinoma. </h2>
                <p style="font-size: 14px; text-align: justify; margin-top: -10px; margin-bottom: 10px;"> Stur E, Peng F, Teng PN, Bayraktar E, Hu M, Corvigno S, Brown DJ, Lee S, Moore KN, Bateman NW, Darcy KM, Maxwell GL, P Conrads T, Sahni N, Vázquez-García I, Shah SP, Celestino J, D Fleming N, Navin NE, Wang L, Sood AK.</p>
         
                <table role="presentation" width="100%" cellspacing="0" cellpadding="0" style="font-size:16px; margin-bottom: 12px;">
                    <tr>
                        <td align="left" style="font-style: italic;">
                            Source: MED
                        </td>
                        <td align="right" style="font-style: italic;">
                            Published: 2025-04-25
                        </td>
                    </tr>
                </table>
            
                <p><span style="background-color: #f4dbac; color: #000000; padding: 4px 8px; border-radius: 12px; font-size: 14px; box-shadow: 1px 1px 3px rgba(0, 0, 0, 1);">bioinformatics, workflow, automated</span></p>
                <p style="font-size: 16px; text-align: justify; margin-bottom: 10px;"><span style="font-weight: bold; font-size: 16px;">tl;dr:</span> We show that cross-communication between the epithelial and immune compartments is important for immune suppression in HGSC, and show that immune-modulating drugs could have implications for the design of clinical trials.</p><p style="font-size: 16px; text-align: justify;"><span style="font-weight: bold; font-size: 16px;">Abstract:</span> Patients with high-grade serous ovarian carcinoma (HGSC) are usually diagnosed with advanced-stage disease, and the tumors often have immunosuppressive characteristics. Together, these factors are important for disease progression, drug resistance, and mortality. In this study, we used a combination of single-cell sequencing and spatial transcriptomics to identify the molecular mechanisms that lead to immunosuppression in HGSC. Primary tumors consistently showed a more active immune microenvironment than did omental tumors. In addition, we found that untreated primary tumors were mostly populated by dysfunctional CD4 and CD8 T cells in later stages of differentiation; this, in turn, was correlated with expression changes in the interferon α and γ pathways in epithelial cells, showing that cross-communication between the epithelial and immune compartments is important for immune suppression in HGSC. These findings could have implications for the design of clinical trials with immune-modulating drugs.</p>
                <p><a href="https://pubmed.ncbi.nlm.nih.gov/40281242/" style="color: #1a0dab; font-size: 16px;">Read full paper</a></p>
            </div>
            <hr style="border: none; border-top: 1px solid #ccc;">
        

            <div style="margin-bottom: 30px;">
                <h2 style="color: #000000; font-size: 22px;">Single-cell RNA sequencing dissects the immunosuppressive signatures in Helicobacter pylori-infected human gastric ecosystem. </h2>
                <p style="font-size: 14px; text-align: justify; margin-top: -10px; margin-bottom: 10px;"> Hu W, Chen ZM, Wang Y, Yang C, Wu ZY, You LJ, Zhai ZY, Huang ZY, Zhou P, Huang SL, Li XX, Yang GH, Bao CJ, Cui XB, Xia GL, Ou Yang MP, Zhang L, Wu WKK, Li LF, Tan LK, Zhang YX, Gong W.</p>
         
                <table role="presentation" width="100%" cellspacing="0" cellpadding="0" style="font-size:16px; margin-bottom: 12px;">
                    <tr>
                        <td align="left" style="font-style: italic;">
                            Source: MED
                        </td>
                        <td align="right" style="font-style: italic;">
                            Published: 2025-04-25
                        </td>
                    </tr>
                </table>
            
                <p><span style="background-color: #f4dbac; color: #000000; padding: 4px 8px; border-radius: 12px; font-size: 14px; box-shadow: 1px 1px 3px rgba(0, 0, 0, 1);">bioinformatics, workflow, automated</span></p>
                <p style="font-size: 16px; text-align: justify; margin-bottom: 10px;"><span style="font-weight: bold; font-size: 16px;">tl;dr:</span> A single-cell analysis of H. pylori-inhabited stomachs reveals a human gastric ecosystem reprogrammed by the pathogen, which leads to impaired antigen presentation and phagocytosis function.</p><p style="font-size: 16px; text-align: justify;"><span style="font-weight: bold; font-size: 16px;">Abstract:</span> Helicobacter pylori (H. pylori) manipulates the host immune system to establish a persistent colonization, posing a serious threat to human health, but the mechanisms remain poorly understood. Here we integrate single-cell RNA sequencing and TCR profiling for analyzing 187,192 cells from 11 H. pylori-negative and 12 H. pylori-positive individuals to describe the human gastric ecosystem reprogrammed by H. pylori infection, as manifested by impaired antigen presentation and phagocytosis function. We further delineate a monocyte-to-C1QC+ macrophage differentiation trajectory driven by H. pylori infection, while T cell responses exhibit broad functional impairment and hyporesponsiveness with restricted clonal expansion capacity. We also identify an HLA-DRs- and CTLA4-expressing T cell population residing in H. pylori-inhabited stomach that potentially contribute to immune evasion. Together, our findings provide single-cell resolution information into the immunosuppressive microenvironment shaped by H. pylori infection, offering critical insights for developing novel therapeutic approaches to eliminate this globally prevalent pathogen.</p>
                <p><a href="https://pubmed.ncbi.nlm.nih.gov/40281037/" style="color: #1a0dab; font-size: 16px;">Read full paper</a></p>
            </div>
            <hr style="border: none; border-top: 1px solid #ccc;">
        

            <div style="margin-bottom: 30px;">
                <h2 style="color: #000000; font-size: 22px;">Protecting centrosomes from fracturing enables efficient cell navigation.</h2>
                <p style="font-size: 14px; text-align: justify; margin-top: -10px; margin-bottom: 10px;"> Schmitt MT, Kroll J, Ruiz-Fernandez MJA, Hauschild R, Ghosh S, Kameritsch P, Merrin J, Schmid J, Stefanowski K, Thomae AW, Cheng J, Öztan GN, Konopka P, Ortega GC, Penz T, Bach L, Baumjohann D, Bock C, Straub T, Meissner F, Kiermaier E, Renkawitz J.</p>
         
                <table role="presentation" width="100%" cellspacing="0" cellpadding="0" style="font-size:16px; margin-bottom: 12px;">
                    <tr>
                        <td align="left" style="font-style: italic;">
                            Source: MED
                        </td>
                        <td align="right" style="font-style: italic;">
                            Published: 2025-04-25
                        </td>
                    </tr>
                </table>
            
                <p><span style="background-color: #f4dbac; color: #000000; padding: 4px 8px; border-radius: 12px; font-size: 14px; box-shadow: 1px 1px 3px rgba(0, 0, 0, 1);">bioinformatics, workflow, automated</span></p>
                <p style="font-size: 16px; text-align: justify; margin-bottom: 10px;"><span style="font-weight: bold; font-size: 16px;">tl;dr:</span> We show that centrosomes can deform and even fracture under mechanical forces, and show that the integrity of centrosome stability preservation is fundamental to cellular function.</p><p style="font-size: 16px; text-align: justify;"><span style="font-weight: bold; font-size: 16px;">Abstract:</span> The centrosome is a microtubule orchestrator, nucleating and anchoring microtubules that grow radially and exert forces on cargos. At the same time, mechanical stresses from the microenvironment and cellular shape changes compress and bend microtubules. Yet, centrosomes are membraneless organelles, raising the question of how centrosomes withstand mechanical forces. Here, we discover that centrosomes can deform and even fracture. We reveal that centrosomes experience deformations during navigational pathfinding within motile cells. Coherence of the centrosome is maintained by Dyrk3 and cNAP1, preventing fracturing by forces. While cells can compensate for the depletion of centriolar-based centrosomes, the fracturing of centrosomes impedes cellular function by generating coexisting microtubule organizing centers that compete during path navigation and thereby cause cellular entanglement in the microenvironment. Our findings show that cells actively maintain the integrity of the centrosome to withstand mechanical forces. These results suggest that centrosome stability preservation is fundamental, given that almost all cells in multicellular organisms experience forces.</p>
                <p><a href="https://pubmed.ncbi.nlm.nih.gov/40279414/" style="color: #1a0dab; font-size: 16px;">Read full paper</a></p>
            </div>
            <hr style="border: none; border-top: 1px solid #ccc;">
        
        <p style="font-size: 14px; color: gray;">
            You’re receiving this email because you're using
            <a href="https://github.com/felipevzps/paper-trackr" style="color: #1a0dab; text-decoration: none;">paper-trackr</a>.
            Stay curious!
        </p>
    </div>
</body>
</html>

